The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlbion. Dev Vct Regulatory News (AADV)

Share Price Information for Albion. Dev Vct (AADV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.00
Bid: 83.50
Ask: 86.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.593%)
Open: 85.00
High: 85.00
Low: 85.00
Prev. Close: 85.00
AADV Live PriceLast checked at -
Albion Development VCT is an Investment Trust

To provide investors with regular dividend income combined with long-term capital growth by investing in a broad portfolio of higher growth businesses with a stronger focus on technology companies across a variety of sectors in UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Albion Development VCT PLC - Ordinary Shares : Interim Management Statement

6 Nov 2018 16:24



Albion Development VCT PLC - Ordinary Shares : Interim Management Statement

Albion Development VCT PLC Interim Management StatementLEI Code 213800FDDMBD9QLHLB38

IntroductionI am pleased to present Albion Development VCT PLC (the “Company”)’s interim management statement for the period from 1 July 2018 to 30 September 2018.

Performance and dividendsThe Company’s unaudited net asset value (NAV) as at 30 September 2018 was £60.5 million or 80.4 pence per share (excluding treasury shares), after accounting for the dividend of 2.0 pence per share paid on 28 September 2018 to shareholders on the register on 14 September 2018.

Albion VCTs Prospectus Top Up Offers 2018/19The Company announced on 6 November 2018 that, subject to obtaining the requisite regulatory approval, it is the Company’s intention to launch a prospectus top up offer to raise up to £6 million before issue costs, with a further over-allotment facility of £2 million, of new Ordinary shares for subscription in the 2018/19 and 2019/20 tax years. Full details of the offer will be contained in a prospectus that is expected to be published in early January 2019.

Share issues During the period from 1 July 2018 to 30 September 2018, the Company issued the following shares under the dividend reinvestment scheme (and are included in the net asset value figures for 30 September 2018 above): 

DateNumber of shares issuedIssue price per shareNet invested £’000
28 September 2018316,89178.9 pence248

Share buybacks During the period from 1 July 2018 to 30 September 2018, the Company purchased 109,000 Ordinary shares for £78,000 at an average price of 71.2p pence per Ordinary share. All of the shares are to be held in treasury.

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.

PortfolioThe following investments have been made during the period from 1 July 2018 to 30 September 2018:

New investments£000sActivity
Phrasee Limited410AI platform that generates optimised marketing campaigns
Arecor Limited224Development of biopharmaceuticals through the application of a formulation technology platform
Forward Clinical Limited190A secure mobile communication and collaboration platform in healthcare
ePatient Network Limited135Online community connecting people affected by rare diseases with up-to-date scientific information, community insights and medical research
Total new investments959 

Further investments£000sActivity
Locum’s Nest Limited440Provides a technology solution for the management of locum doctors for the NHS
Quantexa Limited411Network analytics platform to detect financial crime
Total further investments851 

Top ten holdings as at 30 September 2018:

InvestmentValue£000s% of net asset valueActivity
Radnor House School (Holdings) Limited 6,634 11.0%Independent schools for children aged 5-18
Egress Software Technologies Limited 3,216 5.3%Encrypted email & file transfer service provider
Quantexa Limited 3,010 5.0%Network analytics platform to detect financial crime
Chonais River Hydro Limited 2,373 3.9%Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands
Proveca Limited 2,320 3.8%Reformulation of paediatric medicines
The Street by Street Solar Programme Limited 2,169 3.6%Owns and operates photovoltaic systems on domestic properties in the UK
Regenerco Renewable Energy Limited 1,894 3.1%Generator of renewable energy from roof top solar installations
G.Network Communications Limited 1,796 3.0%Ultra-fast fibre optic broadband provider in central London
Bravo Inns II Limited 1,413 2.3%Owner and operator of freehold pubs
Alto Prodotto Wind Limited 1,391 2.3%Owns and operates community scale wind energy projects on brownfield sites in the UK

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AADV, by following the ‘Portfolio of Investments’ link under the ‘Fund reports’ section.

Material events and transactions after the period end

Portfolio

After the period end, the Company had made the following material investment transactions:

Investment of £120k in an existing portfolio company, Cisiv Limited, which develops software and services for non-interventional clinical trials.

Further informationThe Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this Scheme can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/AADV.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website under www.albion.capital/funds/AADV.

Geoffrey Vero, Chairman

6 November 2018For further information please contact:Patrick Reeve, Albion Capital Group LLP – Tel: 020 7601 1850


Date   Source Headline
16th Sep 20085:25 pmRNSTransaction in Own Shares
11th Sep 20085:27 pmRNSTransaction in Own Shares
9th Sep 20089:52 amRNSDoc re. FSA viewing facility
3rd Sep 20084:32 pmRNSTransaction in Own Shares
29th Aug 20085:02 pmRNSTotal Voting Rights
27th Aug 20086:28 pmRNSInterim Results
31st Jul 20084:43 pmRNSTotal Voting Rights
30th Jun 20085:58 pmRNSTotal Voting Rights
27th Jun 20084:26 pmRNSTransaction in Own Shares
20th Jun 20082:58 pmRNSTransaction in Own Shares
12th Jun 20083:00 pmRNSDirector/PDMR Shareholding
12th Jun 20082:31 pmRNSTransaction in Own Shares
10th Jun 20084:03 pmRNSDirector/PDMR Shareholding-Am
10th Jun 20083:32 pmRNSDirector/PDMR Shareholding
3rd Jun 20082:22 pmRNSDirector/PDMR Shareholding
2nd Jun 200811:45 amRNSDoc re. Sale of Investment -
30th May 20084:41 pmRNSTotal Voting Rights
19th May 200812:09 pmRNSInterim Management Statement
30th Apr 20085:00 pmRNSTotal Voting Rights
30th Apr 20081:14 pmRNSDoc re. Close Period
22nd Apr 20086:10 pmRNSAnnual Information Update
16th Apr 20089:05 amRNSFSA viewing facility
7th Apr 20085:28 pmRNSDoc re. Close Period
7th Apr 20085:22 pmRNSFinal Results - Replacement
7th Apr 20084:55 pmRNSFinal Results
31st Mar 20085:06 pmRNSTotal Voting Rights
29th Feb 20085:26 pmRNSTotal Voting Rights
31st Jan 20084:42 pmRNSTotal Voting Rights
3rd Jan 20084:21 pmRNSTotal Voting Rights
2nd Jan 20085:13 pmRNSDirectorate Change
17th Dec 20075:19 pmRNSTransaction in Own Shares
30th Nov 20075:08 pmRNSTotal Voting Rights
21st Nov 20075:11 pmRNSTransaction in Own Shares
20th Nov 20075:30 pmRNSTransaction in Own Shares
15th Nov 20071:04 pmRNSNet Asset Value(s)
5th Nov 20073:31 pmRNSTransaction in Own Shares
2nd Nov 20071:05 pmRNSDirectorate Change
31st Oct 20074:51 pmRNSTotal Voting Rights
1st Oct 20074:21 pmRNSTotal Voting Rights
28th Sep 20079:55 amRNSTransaction in Own Shares
20th Sep 20075:29 pmRNSTransaction in Own Shares
13th Sep 20075:23 pmRNSTransaction in Own Shares
10th Sep 20075:33 pmRNSTransaction in Own Shares
3rd Sep 20075:20 pmRNSTotal Voting Rights
30th Aug 200712:25 pmRNSInterim Results
1st Aug 20074:36 pmRNSTotal Voting Rights
13th Jul 200710:59 amRNSNet Asset Value(s)
2nd Jul 20071:15 pmRNSDirectorate Change
2nd Jul 200711:35 amRNSTotal Voting Rights
29th Jun 20071:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.